Glatiramer Acetate [Design Issues]

posted by cakhatri – India, 2014-03-02 15:25 (4499 d 02:14 ago) – Posting: # 12544
Views: 7,099

Dear Members,
We have a requirement on conduct of study on Glatiramer acetate injection (20mg) for USFDA submission. The study is to be conducted in India. There are no FDA guidelines on conduct of the study for ANDA submission.Can anyone share their experience in conducting study with this molecule
Regards
Chirag

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
404 visitors (0 registered, 404 guests [including 19 identified bots]).
Forum time: 18:40 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5